RJA
CDNA icon

Raymond James & Associates’s CareDx CDNA Stock Holding History

Raymond James & Associates’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$266K Sell
8,516
-12,633
-60% -$314K ﹤0.01% 3464
2024
Q2 		$328K Sell
21,149
-26,069
-55% -$315K ﹤0.01% 3325
2024
Q1 		$500K Sell
47,218
-29,619
-39% -$296K ﹤0.01% 3064
2023
Q4 		$922K Buy
76,837
+7,270
+10% +$59.6K ﹤0.01% 2561
2023
Q3 		$487K Sell
69,567
-12,124
-15% -$112K ﹤0.01% 2910
2023
Q2 		$694K Sell
81,691
-5,070
-6% -$42.3K ﹤0.01% 2706
2023
Q1 		$793K Buy
86,761
+3,585
+4% +$45.9K ﹤0.01% 2613
2022
Q4 		$949K Sell
83,176
-69,920
-46% -$1.04M ﹤0.01% 2460
2022
Q3 		$2.61M Buy
153,096
+4,464
+3% +$95.8K ﹤0.01% 1804
2022
Q2 		$3.19M Buy
148,632
+2,212
+2% +$61.3K ﹤0.01% 1707
2022
Q1 		$5.42M Buy
146,420
+9,067
+7% +$353K ﹤0.01% 1455
2021
Q4 		$6.25M Sell
137,353
-3,158
-2% -$165K 0.01% 1404
2021
Q3 		$8.9M Buy
140,511
+38,168
+37% +$2.91M 0.01% 1122
2021
Q2 		$9.37M Sell
102,343
-1,816
-2% -$144K 0.01% 1109
2021
Q1 		$7.09M Buy
104,159
+38,888
+60% +$3.02M 0.01% 1220
2020
Q4 		$4.73M Sell
65,271
-21,833
-25% -$1.27M 0.01% 1374
2020
Q3 		$3.31M Sell
87,104
-15,733
-15% -$531K ﹤0.01% 1445
2020
Q2 		$3.64M Sell
102,837
-1,031
-1% -$29.3K ﹤0.01% 1381
2020
Q1 		$2.27M Sell
103,868
-29,360
-22% -$658K ﹤0.01% 1497
2019
Q4 		$2.87M Buy
133,228
+19,362
+17% +$444K ﹤0.01% 1608
2019
Q3 		$2.58M Buy
113,866
+31,874
+39% +$883K ﹤0.01% 1626
2019
Q2 		$2.95M Buy
81,992
+6,958
+9% +$223K ﹤0.01% 1558
2019
Q1 		$2.37M Buy
+75,034
New +$2.19M ﹤0.01% 1655

Other funds holding CDNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James & Associates's CDNA Position: Q3 2024 in Review

Raymond James & Associates reduced its CareDx (CDNA) stake by 60% in Q3 2024, selling an estimated $314K and leaving 8,516 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3464.

Raymond James & Associates first reported a position in CDNA in Q1 2019 and has held it in 23 quarters since. The position peaked at $9.37M in Q2 2021. 215 funds tracked by Wall St. Rank hold CDNA as of Q3 2024.

  • Raymond James & Associates held 8,516 shares of CareDx worth $266K as of Q3 2024.
  • Raymond James & Associates sold 12,633 CareDx shares in Q3 2024, an estimated $314K.
  • CareDx made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3464 holding.
  • Raymond James & Associates first reported a position in CareDx in Q1 2019 and has held it in 23 quarters since.
  • Raymond James & Associates's CareDx position peaked at $9.37M in Q2 2021.
  • 215 funds tracked by Wall St. Rank held CareDx as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.